Cargando...
The impact of COVID-19 on the cell and gene therapies industry: Disruptions, opportunities, and future prospects
Coronavirus 2019 (COVID-19) has caused significant disruption to the cell and gene therapy (CGT) industry, which has historically faced substantial complexities in supply of materials, and manufacturing and logistics processes. As decision-makers shifted their priorities to COVID-19-related issues,...
Guardado en:
| Publicado en: | Drug Discov Today |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8057929/ https://ncbi.nlm.nih.gov/pubmed/33892148 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drudis.2021.04.020 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|